Explainer | New Botox alternative Daxxify is a longer lasting anti-wrinkle injectable that’s made without human or animal ingredients

Daxxify, made of peptides rather than human or animal ingredients, will be the first significant rival to Botox in decades once it hits the market, experts say

While most injectables promise effects that can last three to four months, clinical studies suggest the effects of Daxxify might last up to nine months

Reading Time:2 minutes

Daxxify is a soon-to-be-launched botulinum toxin injectable that threatens to displace Botox as the go-to formula for reducing the appearance of fine lines and wrinkles.

Published: 5:15pm, 3 Oct 2022Updated: 4:36am, 8 Oct 2022

Botulinum toxin injectables, known by brand names such as Botox, Dysport and Jeuveau, have been the go-to formulas for those who want to reduce the appearance of fine lines and wrinkles for years.

Botox stands out as the customers’ favourite, ranking first on the list of minimally invasive cosmetic procedures in the United States.

From 2000 to 2020, Botox injections increased by 459 per cent and that number is expected to continue growing.

However, a new player has entered the game, and threatens to usurp Botox’s rule as soon as it becomes available. Say hello to Daxxify, a peptide-formulated aesthetic injection that experts say will be the first significant rival to Botox in decades.

Daxxify is a new competitor to Botox. It is the only formula stabilised with peptide technology and 100 per cent free of human- or animal-based ingredients.

What is Daxxify?

Daxxify is a neuromodulator used to temporarily lessen the appearance of lines and wrinkles. The formula has been in the works for years and was approved by the United States’ Federal Drug Administration (FDA) on September 8.